These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8047714)

  • 1. Use of flutter VRP1 in the management of patients with steroid-dependent asthma.
    Swift GL; Rainer T; Saran R; Campbell IA; Prescott RJ
    Respiration; 1994; 61(3):126-9. PubMed ID: 8047714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Flutter VRP1: a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma.
    Girard JP; Terki N
    J Investig Allergol Clin Immunol; 1994; 4(1):23-7. PubMed ID: 8081537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute effect of use of the Flutter on expectoration of sputum in patients with chronic respiratory diseases].
    Nakamura S; Kawakami M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Feb; 34(2):180-5. PubMed ID: 8622274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of Flutter®VRP1 components on mucus transport of patients with bronchiectasis.
    Tambascio J; de Souza LT; Lisboa RM; Passarelli Rde C; de Souza HC; Gastaldi AC
    Respir Med; 2011 Sep; 105(9):1316-21. PubMed ID: 21641196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical behaviors of Flutter VRP1, Shaker, and Acapella devices.
    dos Santos AP; Guimarães RC; de Carvalho EM; Gastaldi AC
    Respir Care; 2013 Feb; 58(2):298-304. PubMed ID: 22906833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of the FLUTTER VRP1 device for physiotherapy patients with chronic pulmonary disease].
    Lubiński W; Targowski T; Frank-Piskorska A
    Pol Merkur Lekarski; 2000 Jan; 7(43):37-40. PubMed ID: 10765651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial.
    Dwyer TJ; Zainuldin R; Daviskas E; Bye PT; Alison JA
    BMC Pulm Med; 2017 Jan; 17(1):14. PubMed ID: 28077104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis.
    Thompson CS; Harrison S; Ashley J; Day K; Smith DL
    Thorax; 2002 May; 57(5):446-8. PubMed ID: 11978924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter.
    Volsko TA; DiFiore J; Chatburn RL
    Respir Care; 2003 Feb; 48(2):124-30. PubMed ID: 12556253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of PEP mask and Flutter on expectoration in cystic fibrosis patients.
    Borka P; Gyurkovits K; Bódis J
    Acta Physiol Hung; 2012 Sep; 99(3):324-31. PubMed ID: 22982720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flutter-VRP1 Desitin--a new physiotherapeutic device for the treatment of chronic obstructive bronchitis.
    Leru P; Bistriceanu G; Ibraim E; Stoicescu P
    Rom J Intern Med; 1994; 32(4):315-20. PubMed ID: 7613505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective measurements of compliance in asthma treatment.
    Chmelik F; Doughty A
    Ann Allergy; 1994 Dec; 73(6):527-32. PubMed ID: 7998669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance analysis of the Flutter VRP1 under different flows and angles.
    Alves LA; Pitta F; Brunetto AF
    Respir Care; 2008 Mar; 53(3):316-23. PubMed ID: 18291047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
    Lock SH; Kay AB; Barnes NC
    Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of perception of severity of asthma: patients treated in general practice.
    Kendrick AH; Higgs CM; Whitfield MJ; Laszlo G
    BMJ; 1993 Aug; 307(6901):422-4. PubMed ID: 8374455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.
    van den Berge M; Arshad SH; Ind PW; Magnussen H; Hamelmann E; Kanniess F; Postma DS
    Respir Med; 2009 Aug; 103(8):1216-23. PubMed ID: 19297141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial.
    Choi IS; Koh YI
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):584-91. PubMed ID: 12086366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a positive expiratory pressure device in conjunction with beta2-agonist nebulization therapy for bronchial asthma.
    Tsai CF; Tsai JJ
    J Microbiol Immunol Infect; 2001 Jun; 34(2):92-6. PubMed ID: 11456366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification of bronchial asthma according to steroid and immunosuppressive treatment].
    Nagasaka Y; Nakajima S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():134-9. PubMed ID: 8752496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous positive airway pressure in acute asthma.
    Shivaram U; Donath J; Khan FA; Juliano J
    Respiration; 1987; 52(3):157-62. PubMed ID: 3326082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.